Samjin to export clopidogrel bisulfate technology to Indonesia
Published: 2011-11-09 06:58:00
Updated: 2011-11-09 06:58:00
Samjin Pharmaceutical said Monday it has signed a contract ro supply an Indonesian company with a technology that helps the manufacture of clopidogrel bisulfate, an antiplatelet agent used to inhibit blood clots in coronary artery disease, following China and the Philippines.
Under the contrac...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
